The burgeoning interest in natural components in personal care products has led to significant research and development of ingredients such as plant extracts, antioxidants, peptides, and probiotics. These components have been recognized for their potential to enhance skin health through various mechanisms, addressing consumer demand for products that are both effective and benign. Plant extracts, known for their rich composition of bioactive compounds, offer a myriad of benefits including antioxidant, anti-inflammatory, and antimicrobial properties, making them invaluable in skin care formulations. Antioxidants, derived from both plants and other natural sources, play a pivotal role in protecting the skin from oxidative damage, thereby preventing premature aging and promoting skin vitality. Bioactive peptides have garnered attention owing to their multifunctional activities that include promoting collagen synthesis, inhibiting enzymes responsible for skin degradation, and reducing inflammation, thereby contributing to skin regeneration and anti-aging. Probiotics have expanded their utility beyond gut health to skin care, where they help in maintaining skin microbiome balance, thus enhancing skin barrier function and potentially mitigating various skin disorders. The purpose of this review is to explore the individual roles of plant extracts, antioxidants, peptides, and probiotics in personal care products, while emphasizing their synergistic effects when combined. By integrating these natural components, this paper aims to highlight the potential for developing innovative skincare formulations that not only address specific skin concerns but also contribute to overall skin health, aligning with the increasing consumer preference for natural and holistic skincare solutions.

The present study aimed to compare the potential anti-adipogenic effects and underlying mechanisms of the luteolin, isoscoparin and isoorientin flavonoids, purified from Triticum aestivum sprout (TA) in 3T3-L1 cells. The cells were treated with different concentrations of flavonoids for 8 days and the lipid accumulation was assessed using Oil-Red-O staining. The expression levels of the transcription factors and the genes involved in adipogenesis in the cells were assessed by reverse transcription-quantitative polymerase chain reaction and western blotting. The results demonstrated that 10 μM luteolin, isoscoparin or isoorientin inhibited lipid deposition in the cells by 74, 63 and 65%, respectively. The flavonoids also significantly inhibited the transcriptional regulators of adipogenesis, including peroxisome proliferator-activated receptor-γ, CAAT/enhancer binding protein-α and sterol regulatory element binding protein (SREBP)-1c, compared with the control cells. Similarly, there was a significant downregulation of the adipocyte specific markers associated with lipid metabolism, including activating protein-2, fatty acid synthase, hormone-sensitive lipase and lipoprotein lipase, in the flavonoid treated cells. Notably, the cells treated with the flavonoids demonstrated increased expression levels of the insulin-induced genes, insig-1 and insig-2, which may have inhibited the activation of the adipogenic transcription factor, SREBP, eventually leading to the inhibition of adipogenesis. Taken together, these results revealed that the flavonoids from TA possessed an inhibitory effect on adipogenesis through downregulation of adipogenic transcription factors and genes associated with lipid metabolism, and the upregulation of insig 1 and 2, suggesting that the flavonoids from TA may be potential therapeutic agents for the prevention and treatment of obesity.